1 Benzoni G, Foresti F, Archetti L, et al. Specific and non-specific immunity of piglets from sows fed diets containing specific fatty acids in field conditions[J]. J Anim Physiol Anim Nutr (Berl), 2013, 97(5): 996~1005.2 Chen X, Ren F, Hesketh J, et al. Selenium blocks porcine circovirus type 2 replication promotion induced by oxidative stress by improving GPx1 expression[J]. Free Radic Biol Med, 2012, 53(3): 395~405.3 Fraile L, Grau-Roma L, Sarasola P, et al. Inactivated PCV2 one shot vaccine applied in 3-week-old piglets: Improvement of production parameters and interaction with maternally derived immunity[J]. Vaccine, 2012, 30(11): 1986~1992.4 Fu F, Tian H, Li X, et al. C-terminal heat shock protein 70 of Mycobacterium tuberculosis as a molecular adjuvant for DNA vaccination with the porcine circovirus type 2 ORF2 (capsid) gene in mice[J]. Vet J, 2013, 195(2): 244~247.5 Genmei L, Manlin L, Ruiai C, et al. Construction and immunogenicity of recombinant adenovirus expressing ORF2 of PCV2 and porcine IFN gamma[J]. Vaccine, 2011, 29(47): 8677~8682.6 Grau-Roma L, Fraile L, Segalés J. Recent advances in the epidemiology, diagnosis and control of diseases caused by porcine circovirus type 2[J]. Vet J, 2011, 187(1): 23~32.7 Huang L, Lu Y, Wei Y, et al. Construction and biological characterisation of recombinant porcine circovirus type 2 expressing the V5 epitope tag[J]. Virus Res, 2011a, 161(2): 115~123.8 Huang Y L, Pang V F, Lin C M, et al. Porcine circovirus type 2 (PCV2) infection decreases the efficacy of an attenuated classical swine fever virus (CSFV) vaccine[J]. Vet Res, 2011b, 42(1): 115.9 Liu J, Huang L, Wei Y, et al. Amino acid mutations in the capsid protein produce novel porcine circovirus type 2 neutralizing epitopes[J]. Vet Microbiol, 2013, 165(3~4): 260~267.10 O’Neill K C, Shen H G, Lin K, et al. Studies on porcine circovirus type 2 vaccination of 5-day-old piglets[J]. Clin Vaccine Immunol, 2011, 18(11): 1865~1871.11 Opriessnig T, Madson D M, Schalk S, et al. Orbivirus infections in collared peccaries (Tayassu tajacu) in southeastern Brazil[J]. J Wildl Dis, 2012, 48(1): 230~232.12 Pei Y, Hodgins D C, Wu J, et al. Porcine reproductive and respiratory syndrome virus as a vector: Immunogenicity of green fluorescent protein and porcine circovirus type 2 capsid expressed from dedicated subgenomic RNAs[J]. Virology, 2009, 389(1~2): 91~99.13 Ren W, Yin Y, Liu G, et al. Effect of dietary arginine supplementation on reproductive performance of mice with porcine circovirus type 2 infection[J]. Amino Acids, 2012, 42(6): 2089~2094.14 Ren W, Luo W, Wu M, et al. Dietary L-glutamine supplementation improves pregnancy outcome in mice infected with type-2 porcine circovirus[J]. Amino Acids, 2013, 45(3): 479~488.15 Saha D, Lefebvre D J, Ooms K, et al. Single amino acid mutations in the capsid switch the neutralization phenotype of porcine circovirus 2[J]. J Gen Virol, 2012a, 93(Pt 7): 1548~1555.16 Saha D, Doorsselaere J V, Nauwynck H J. Instability in vitro of a PCV2 infectious clone containing an insertion between ORF1 and ORF2[J]. Virus Genes, 2012b, 44(2): 258~261.17 Seo H W, Han K, Kim D, et al. Effects of an inactivated porcine circovirus type 2 (PCV2) vaccine on PCV2 virus shedding in semen from experimentally infected boars[J]. Clin Vaccine Immunol, 2011, 18(7): 1091~1096.〖HJ〗18 Shen H G, Beach N M, Huang Y W, et al. Comparison of commercial and experimental porcine circovirus type 2 (PCV2) vaccines using a triple challenge with PCV2, porcine reproductive and respiratory syndrome virus (PRRSV), and porcine parvovirus (PPV)[J]. Vaccine, 2010, 28(37): 5960~5966.19 Stevenson L S, Gilpin D F, Douglas A, et al. T lymphocyte epitope mapping of porcine circovirus type 2[J]. Viral Immunol, 2007, 20(3): 389~398.20 Takahagi Y, Toki S, Nishiyama Y, et al. Differential effects of porcine circovirus type 2 (PCV2) vaccination on PCV2 genotypes at Japanese pig farms[J]. J Vet Med Sci, 2010, 72(1): 35~41.21 Wang Y P, Liu D, Guo L J, et al. Enhanced protective immune response to PCV2 subunit vaccine by co-administration of recombinant porcine IFN-γ in mice[J]. Vaccine, 2013, 31(5): 833~838.22 Wei Y Y, Hu T J, Su Z J, et al. Immunomodulatory and antioxidant effects of carboxymethylpachymaran on the mice infected with PCV2[J]. Int J Biol Macromol, 2012, 50(3): 713~719.23 Weibel H, Sydler T, Brugnera E, et al. Vaccination with Enterisol Ileitis and Ingelvac CircoFLEXTM in a Swiss breeding farm[J]. Schweiz Arch Tierheilkd, 2012, 154(10): 445~450.24 Xu X G, Wang Z S, Zhang Q, et al. Baculovirus as a PRRSV and PCV2 bivalent vaccine vector: Baculovirus virions displaying simultaneously GP5 glycoprotein of PRRSV and capsid protein of PCV2[J]. J Virol Methods, 2012, 179(2): 359~366. |